What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Akimasa Nakao mostly deals with Surgery, Internal medicine, Pathology, Pancreatic cancer and Cancer research.
His Surgery study frequently draws connections between related disciplines such as Cancer.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Resection margin, Endocrinology and Oncology.
His work carried out in the field of Pathology brings together such families of science as Genetic marker, Cell culture and Pancreatic disease.
His biological study spans a wide range of topics, including Clinical trial, Pancreatectomy, Pancreas, General surgery and Stage.
His Cancer research research is multidisciplinary, incorporating perspectives in Tumor progression, Colorectal cancer and Methylation, DNA.
His most cited work include:
- Nutritional predictors of postoperative outcome in pancreatic cancer (321 citations)
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (304 citations)
- Pancreatic Cancer Registry in Japan: 20 years of experience. (258 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Surgery, Pathology, Cancer and Gastroenterology.
Akimasa Nakao interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
His research in Surgery intersects with topics in Radiology and Pancreatic fistula.
His research integrates issues of Cancer research, Metastasis, Pancreas and Adenocarcinoma in his study of Pathology.
His study on Cancer research also encompasses disciplines like
- Methylation and related DNA methylation,
- Tumor suppressor gene together with Molecular biology.
His Pancreatic cancer study combines topics in areas such as Resection and General surgery.
He most often published in these fields:
- Internal medicine (34.02%)
- Surgery (23.46%)
- Pathology (21.81%)
What were the highlights of his more recent work (between 2009-2021)?
- Surgery (23.46%)
- Internal medicine (34.02%)
- Pancreatic cancer (13.85%)
In recent papers he was focusing on the following fields of study:
His main research concerns Surgery, Internal medicine, Pancreatic cancer, Oncology and Cancer.
The concepts of his Surgery study are interwoven with issues in Pancreatic fistula and Pancreas.
His Internal medicine study incorporates themes from Gastroenterology and Pathology.
His Pathology research includes elements of Hepatectomy, Cancer research and Intraductal papillary mucinous neoplasm.
His research in Pancreatic cancer tackles topics such as Radiology which are related to areas like Resection and Pancreatic head.
His study focuses on the intersection of Cancer and fields such as Hepatocellular carcinoma with connections in the field of Gene silencing.
Between 2009 and 2021, his most popular works were:
- Nutritional predictors of postoperative outcome in pancreatic cancer (321 citations)
- Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. (174 citations)
- Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. (127 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Akimasa Nakao focuses on Surgery, Internal medicine, Pancreatic cancer, Cancer and Retrospective cohort study.
His work deals with themes such as Physical therapy, Pancreatic fistula and Hazard ratio, which intersect with Surgery.
Akimasa Nakao has included themes like Gastroenterology and Oncology in his Internal medicine study.
His studies deal with areas such as Prospective cohort study and Pancreas as well as Gastroenterology.
Akimasa Nakao combines subjects such as Carcinoma and Pancreatectomy with his study of Retrospective cohort study.
His Carcinoma research is classified as research in Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
